-
- Up one level
- *Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
These Treatment Guidelines have been developed to inform clinicians how to care for patients with COVID-19. Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines will be updated frequently as published data and other authoritative information becomes available.
- A new antiviral drug heading into clinical trials offers hope for COVID-19 treatment — in part because it can be taken as a pill
April 6, 2020
Scientists are hopeful that a new drug — called EIDD-2801 — could change the way doctors treat COVID-19. The antiviral shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
- Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Mandeep R Mehra, Sapan S Desai, Frank Ruschitzka, Amit N Patel. The Lancet, May 22, 2020
We were unable to confirm a benefit of hydroxychloroquine or chloroquine, when used alone or with a macrolide, on in-hospital outcomes for COVID-19. Each of these drug regimens was associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19.